UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003867 |
|---|---|
| Receipt number | R000004653 |
| Scientific Title | Phase 1 study of fludarabine combined with rituximab followed by Zevalin for patients with relapsed or refractory indolent B cell lymphoma |
| Date of disclosure of the study information | 2010/07/05 |
| Last modified on | 2014/07/04 13:03:35 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/07/04 21:09:15 | ||
| 2 | Update | 2011/07/04 19:37:03 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2014/01/04 10:46:52 | Email |
|
| 4 | Update | 2014/01/04 10:47:38 | Recruitment status |
|
| 5 | Update | 2014/07/04 13:03:35 | Recruitment status Date analysis concluded |
